Polyhexamethylene biguanide for treatmemt of external genital warts: A prospective, double-blind, randomized study

G. Marelli, E. Papaleo, M. Origoni, L. Caputo, A. Ferrari

Research output: Contribution to journalArticle

Abstract

Genital human papillomavirus infection is one of the most common sexually transmitted diseases. Polyhexamethylene biguanide is a new agent, that has been demonstrated to have potent in vivo antiviral effects in animal and in human models. The present prospective, double-blind, randomized, placebo (vehicle-controlled) trial evaluated the efficacy and safety of daily patient-applied polyhexamethylene biguanide for up to 16-weeks for the treatment of external genital warts. Wart recurrence was investigated during a 12-week treatment-free follow-up period. In the intent-to-treat analysis, baseline warts cleared from 49 of 94 (52%) patients treated with polyhexamethylene biguanide cream versus and 3 of 95 (4%) placebo patients; the differences between the groups treated with placebo and polyhexamethylene biguanide were significant (P <0.0001). For subjects who completed the follow-up period, recurrence rates after a complete response were 19% (9 of 48 patients) in the polyhexamethylene biguanide cream group, 17% cream group, and 0% (0 of 3) in the placebo group. There were no systemic reactions, although local skin reactions (generally of mild or moderate severity) were common in the polyhexamethylene biguanide cream group. Local reactions caused two patients to discontinue treatment. The most frequently reported local skin reactions were erythema, excoriation or flaking, and erosion. Patient-applied polyhexamethylene biguanide cream is effective for the treatment of external genital warts and has a favorable safety profile.

Original languageEnglish
Pages (from-to)369-372
Number of pages4
JournalEuropean Review for Medical and Pharmacological Sciences
Volume9
Issue number6
Publication statusPublished - Nov 2005

Keywords

  • Genital warts
  • Papillomavirus infection
  • Polyhexamethylene biguanide

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Polyhexamethylene biguanide for treatmemt of external genital warts: A prospective, double-blind, randomized study'. Together they form a unique fingerprint.

  • Cite this